Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model. (2018)

First Author: Pashayan N

Attributed to: FUTURE TARGETED HEALTHCARE MANUFACTURING HUB funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1001/jamaoncol.2018.1901

PubMed Identifier: 29978189

Publication URI: http://europepmc.org/abstract/MED/29978189

Type: Journal Article/Review

Volume: 4

Parent Publication: JAMA oncology

Issue: 11

ISSN: 2374-2437